Skip to main content
Clinical Trials/TCTR20220516004
TCTR20220516004CompletedPhase 4

The study to evaluate the efficacy and safety of using Platelet-rich plasma for treating melasma in Thailand

Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand0 sites25 target enrollmentStarted: May 16, 2022Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
25

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 60 Years (—)
Sex
All

Inclusion Criteria

  • 1. Epidermal or mixed types melasma2. Thais 3. Healthy

Exclusion Criteria

  • 1. pregnant or lactating woman 2. Having severe acnes 3. Having the skin disease around the treated area 4. Using an energy-based device or other interventions around treated area 6 months prior

Investigators

Sponsor
Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand

Similar Trials